Search





Results 1-10 of 24.
 |   | 
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC1117412018225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot studySATHEKGE MIKE; BRUCHERTSEIFER FRANK; KNOESEN OTTO; REYNEKE F; LAWAL I; LENGANA T; DAVIS CINDY; MAHAPANE JOHNCY; CORBETT CECELIA; VORSTER MARIZA; MORGENSTERN ALFRED
JRC1132982018Theranostic approach in ovarian cancer using Anti-MISRII radiolabeled antibodiesPOUGET JEAN-PIERRE; DESHAYES EMMANUEL; LADJOHOUNLOU RIAD; LE FUR PIERRE; PICHARD ALEXANDRE; LOZZA CATHERINE; KASHANI ROXANA; KOCH JOANNA; FOSTER JULIE; SOSABOWSKI JANE; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; CHOUIN N; NAVARRO-TEULON ISABELLE
JRC1132962018Initial clinical experience performing sialendoscopy for salivary glands protection for patients under 225Ac-PSMA-617-RLTRATHKE H; KRATOCHWIL CLEMENS; HOHENBERGER R; GIESEL FREDERIK; BRUCHERTSEIFER FRANK; FLECHSIG PAUL; MORGENSTERN ALFRED; PLINKERT PETER; HABERKORN UWE; BULUT OLCAY CEM
JRC1117832018Enhancing Targeted α-therapy for treatment of metastatic breast cancerNEDROW JESSIE; MCCARTY GREG; JOSEFSSON ANDERS; RAY SANGEETA; CORTEZ ANGEL; SONG HONG; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS G.
JRC1117472018Optimizing the treatment regimen for targeted alpha therapy of mCRPC with 225Ac-PSMA-617KRATOCHWIL CLEMENS; RATHKE H; BRUCHERTSEIFER FRANK; GIESEL FREDERIK; HABERKORN UWE; MORGENSTERN ALFRED
JRC1097042018An overview of targeted alpha therapy with 225Actinium and 213BismuthMORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; KRATOCHWIL CLEMENS; SATHEKGE MIKE; KROLICKI LESZEK; BRUCHERTSEIFER FRANK
JRC1128812018Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian CancerDESHAYES EMMANUEL; LADJOHOUNLOU RIAD; LE FUR PIERRE; PICHARD ALEXANDRE; LOZZA CATHERINE; BOUDOUSQ VINCENT; SEVESTRE SAMUEL; JARLIER MARTA; KASHANI ROXANA; KOCH JOANNA; SOSABOWSKI JANE; FOSTER JULIE; CHOUIN N; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; KOTZKI PIERRE-OLIVIER; NAVARRO-TEULON ISABELLE; POUGET JEAN-PIERRE
JRC1128822018Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: Towards improved alpha-therapeuticsŠIMEČEK JAKUB; HERMANN PETR; SEIDL C.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; WESTER HANS-JÜRGEN; NOTNI JOHANNES
JRC1076052018Spät-Neurotoxizität der diffusiblen Beta-Radiopeptid-Brachytherapie im Vergleich zur AlphatherapieMERLO A.; CORDIER D.; FORRER F.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; MÄCKE H.
JRC1105452018Pharmacokinetic variability of 225Ac and 213Bi from vector labeled 225Ac cancer therapy as a function of vector type (antibody vs. small molecule)JOSEFSSON ANDERS; NEDROW JESSIE; RAY SANGEETA; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; POMPER MARTIN; SGOUROS G.; HOBBS ROBERT F.